Company Description
Sanofi-Aventis helps docs treat their sneezy patients without making them grumpy or dopey. The maker of allergy medicine Allegra specializes in...
Key Sanofi-Aventis Financials
| Company Type | Public - NYSE: SNY; Euronext Paris: SAN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $43,019.0 |
| 2007 Employees | 99,495 |
More Sanofi-Aventis Financials (11 pages)
Latest Sanofi-Aventis Jobs jobs by Indeed
Rankings
- CAC 40
- Dow Jones STOXX 50
- Euronext 100
- #39 in FT Global 500
- SBF 120
- SBF 250
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about Sanofi-Aventis's competition across multiple industries
Top Sanofi-Aventis Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Sanofi-Aventis Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Jean-François Dehecq | Network | E-mail |
| CEO and Director | Gérard Le Fur | Network | E-mail |
| EVP Finance and Legal | Jean-Claude Leroy | Network | E-mail |
More Sanofi-Aventis Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Sanofi-Aventis News
- Terphenyl derivatives, preparation thereof, compositions containing same [U.S. Patents] (01 Jul 2008 13:22:00 EDT)
- Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics [U.S. Patents] (01 Jul 2008 13:22:00 EDT)
- Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or... [U.S. Patents] (01 Jul 2008 13:22:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.